Imagine navigating a global pandemic with the added vulnerability of living with epilepsy. Recent research spearheaded by Swansea University and the University of Edinburgh has shed light on this very scenario, revealing that individuals with epilepsy faced significantly higher risks of hospitalization and mortality due to COVID-19 compared to those without the condition. This study, which delved into the health outcomes of 27,000 people with epilepsy in Wales, underscores the critical need for tailored healthcare strategies to protect this vulnerable group amidst health crises.

The Stark Reality: Increased Risks Uncovered

Through meticulous analysis, researchers found that people with epilepsy experienced a 60% higher rate of COVID-19 hospital admissions and a 33% higher mortality rate than their counterparts without epilepsy. These alarming statistics emerged from a comprehensive review of anonymized health data, encompassing everything from GP service use to hospital admissions and causes of death, collected from the 3 million residents of Wales. The study, which spanned from March 1, 2020, to June 30, 2021, not only highlighted the exacerbated risks faced by individuals with epilepsy during the pandemic but also pointed to a decrease in new epilepsy diagnoses and reduced health service contact among this demographic.

Delving Deeper: The Need for Further Investigation

While the findings are unequivocal, they beckon a deeper inquiry into why people with epilepsy are more susceptible to severe COVID-19 outcomes. The research team, led by Dr. Owen Pickrell of Swansea University Medical School and Professor Richard Chin of Edinburgh University, emphasized the importance of understanding these dynamics to inform healthcare planning and resource allocation. This call to action is not only a testament to the value of using routinely collected health data but also highlights the ongoing need for informed healthcare resources tailored to individuals living with long-term conditions like epilepsy.

Towards a Healthier Future: The Path Ahead

The implications of this study are far-reaching, advocating for a paradigm shift in how healthcare systems approach and prioritize care for people with epilepsy, especially in the face of global health emergencies. By leveraging the insights garnered from this research, healthcare providers and policymakers can develop more targeted strategies to mitigate the risks associated with infectious diseases like COVID-19 for those living with epilepsy. Moreover, this study serves as a clarion call for the continuation of collaborative research efforts, such as those supported by Health and Care Research Wales and Epilepsy Action, to harness the potential benefits of routinely collected health data in shaping a more inclusive and responsive healthcare landscape.


Source:, Ethan Sulliva